Subscribe to RSS
Download PDF
DOI: 10.1160/TH06-11-0628
Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus
Financial support: This study was supported by a ,,Mecenatura Grant” 2002 of the Medical and Health Science Center at the University of Debrecen, OTKA grant T049392, and the Bóyai János fellowship.
Publication History
Received
06 November 2007
Accepted after resubmission
03 April 2007
Publication Date:
29 November 2017 (online)
Summary
Increased levels of soluble P-selectin (sP-selectin) have been shown in a number of different disorders, e.g. diabetes mellitus (DM) and cardiovascular disease (CVD). Several studies have attempted to demonstrate the association of the most intensively examined variant of P-selectin gene polymorphism (Thr715Pro) with sP-selectin levels in healthy subjects and in CVD, but contradictory data have been reported.To clarify the effect of Pro715 allele on the sP-selectin levels in type 2 DM, we analysed this polymorphism in diabetic patients and compared these data with sP-selectin levels. Type 2 DM patients (n=119), 48 BMImatched non diabetic individuals – consisting mostly of overweight subjects – and 57 healthy volunteers were included in the study.TheThr715Pro polymorphism was analysed by PCR-RFLP, while sP-selectin levels were measured by ELISA. Significantly elevated sP-selectin levels were found in both DM and in overweight subjects compared to healthy controls. We confirmed previous reports that in healthy Pro715 allele carriers lower sP-selectin levels could be measured; however, this difference was only significant in case of lean subjects. No significant difference was detected in sP-selectin level among DM and overweight individuals according to this genotype. However, significant difference was observed in sP-selectin levels in older DM patients compared to younger ones,but these levels were not accounted for by the Thr715Pro polymorphism.We suggest that in type 2 DM individuals, the significantly elevated sP-selectin levels are not due to the Thr715Pro P-selectin gene polymorphism.
-
References
- 1 McEver RP. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16: 73-80.
- 2 Kappelmayer J, Nagy Jr B, Miszti-Blasius K. et al. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004; 42: 475-486.
- 3 Stenberg PE, McEver RP, Shuman MA. et al. A platelet alpha-granule membrane protein(GMP-140)is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-886.
- 4
Berger G,
Hartwell DW,
Wagner DD.
P-selectin and platelet clearence. Blood 1998; 92: 4446-4452.
MissingFormLabel
- 5 Jilma B, Fasching P, Ruthner C. et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996; 76: 328-332.
- 6 Blann AD, Lip GY, Beevers DG. et al. Soluble P-selectin in atherosclerosis: a comparison withendothelial cell and platelet markers. Thromb Haemost 1997; 77: 1077-1080.
- 7 Tschoepe D, Driesch E, Schwippert B. et al. Activated platelets in subjects at increased risk of IDDM. Diabetologia 1997; 40: 573-577.
- 8 Kopp HP, Hopmeier P, Schernthaner G. Concentrations of circulating P-Selectin are increased in patients with newly diagnosed insulin-dependent dia-Nagy et al. Thr715Pro in type 2 diabetes betes mellitus. Exp Clin Endocrinol Diabet 1998; 106: 41-44.
- 9 Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491-495.
- 10 Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation?. Atherosclerosis 1997; 128: 135-138.
- 11 Herrmann SM, Ricard S, Nicaud V. et al. The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in pateints with myocardial infarction. Hum Mol Genet 1998; 7: 1277-1284.
- 12 Kee F, Morrison C, Evans A. et al. Polymorphisms of the P-selectin gene and therisk of myocardial infarction in men and women in the ECTIM extension study. Heart 2000; 84: 548-552.
- 13 Barbaux SC, Blankenberg S, Rupprecht HJ. et al. Associations between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Atheroscler Thromb Vasc Biol 2001; 21: 1668-1673.
- 14 Carter AM, Anagnostopoulou K, Mansfield MW. et al. Soluble P-selectin levels, P-selectin polymorphisms and cardiovascular disease. J Thromb Haemost 2003; 1: 1718-1723.
- 15 Miller MA, Kerry SM, Dong Y. et al. Associations between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin in a multiethnic population in South London. Thromb Haemost 2004; 92: 1060-1065.
- 16 Liu Y, Burdon KP, Langefeld CD. et al. P-selectin gene haplotype associations with albuminuria in the Diabetes Heart Study. Kidney Int 2005; 68: 741-746.
- 17 Volcik KA, Ballantyne CM, Coresh J. et al. P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: The Atherosclerosis Risk In Communities Study. Atherosclerosis 2006; 186: 74-79.
- 18 Jilma B. The Thr715Pro single nucleotide polymorphism of P-selectin: does it really matter in cardiovascular disorders?. Thromb Haemost 2004; 92: 896-897.
- 19 Tregouet DA, Barbaux S, Escolano S. et al. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 2002; 11: 2015-2023.
- 20 Zalewski G, Ciccarone E, Di Castelnuovo A. et al. P-selectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2006; 16: 418-425.